Health science companies commercializing products and services
in therapeutics, medical devices, diagnostics, digital health and health IT will present at the OBIO® Investment Summit (OIS) from
Feb 14 to 16, 2024.
Since 2018, more than $1.6B has been raised by companies who presented at the Summit.
Companies invited to present:
20/20 OptimEyes Technologies is developing a transformative drug delivery platform for ocular diseases normally controlled by eye drops.
48Hour Discovery is a leading peptide-based company accelerating discovery of novel molecules for the delivery of therapeutic payloads, with a focus on bringing targeted radiopharmaceuticals to market faster than ever before.
Able Innovations is solving the labor-intensive task of lateral patient transfer by developing the ALTA Platform™, a robotic and automated device operated by a single operator.
AIDREA is a versatile AI Platform analyzing endoscopy video images in real-time, improving patient outcomes and workflows.
Altis Labs is the computational imaging company accelerating clinical trials with AI.
AmacaThera is a clinical-stage biotechnology company transforming therapeutics to make a difference in patient health. Their unique, injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes across multiple therapeutic areas, including post‑surgical pain management, cancer and other hard‑to‑reach target areas.
Arrayus Technologies Inc. is a clinical stage medical device company developing an innovative ultrasound-mediated drug delivery platform for use in oncology.
Artificial Intelligence Imaging Sensors (AiimSense Inc.) - Empowering early stroke diagnosis and monitoring through innovative point-of-care imaging.
Asima Health is redefining cancer surveillance with a simple blood test.
Atorvia is pre-clinical stage biotech company developing novel therapeutics for organ failure with a first-in-class drug in development that prevents and treats ischemic injury, initially targeting the kidney.
BioMimir Inc. is a female-founded medical device company that streamlines wound care using bioabsorbable, liquid to solid biomaterials.
Canurta develops novel bioactive products to support inflammation across diverse diseases.
CARE Group revolutionizes personalized evidence-based mental health care with advanced AI and disruptive digital technologies, empowering individuals and communities.
Celestra Health proactively detects Multiple Sclerosis (MS) disease progression before irreversible damage occurs. We use wearable technology powered by our patented AI algorithms to measure disease progression with laboratory-grade precision, at 1/100th of the cost of a state-of-the-art laboratory.
Cerebra Health is a Canadian technology company transforming the future of sleep diagnosis and therapy. Cerebra unites innovators and researchers with the common goal and passion of putting “sleep” back into sleep medicine.
Clairvoyant Therapeutics is a late stage clinical stage biotechnology company changing the face of psychedelic therapy with a speed-to-market clinical strategy designed to enable psilocybin therapy in the EU & Canada to treat patients living with Alcohol Use Disorder (AUD) beginning in 2026.
Cobionix Corporation is a robotics company developing fully autonomous cobots for procedural, repetitive, and complex tasks. The cobots will work collaboratively in the healthcare space to reduce gaps and increase consistency.
Conavi Medical is an early commercial-stage medical device company that has developed the first and only intravascular imaging system that combines ultrasound (IVUS) and optics (OCT) for coronary visualization.
Cosm Medical is personalizing gynecological devices for precision care. With their first Health Canada market approval received, they are serving clinicians and patients by leveraging diagnostics, AI and 3D printing to personalize gynecological devices for unique bodies and needs by establishing a new product category much like the billion-dollar custom dental, orthotics, and hearing industries.
Cove Neurosciences is developing software to enable a new era of precision biomarkers for neurologic and psychiatric diseases, with the goal of developing objective metrics to inform novel therapies for neurological and psychiatric disorders.
Cura Therapeutics is a preclinical (POC) stage biotech company, entering IND-enabling studies in Q1 2024, developing a first-in-class multifunctional immunotherapy drug pipeline to treat a wide range of solid malignancies and infectious diseases. Cura's immunotherapies harness cytokines and receptors to create multifunctional proteins with potent anti-cancer and anti-viral properties.
Difinity Solutions is developing NeedSwitch, the world's first interchangeable and modular autoinjector for emergency medication delivery. It is designed to save lives starting with the opioid crisis, a market worth over $4B per year with further platform applications for other various emergency medications.
Doctalk - Collaborative applications for MDs that make their lives easier. Workflow improvement applications are in 3 categories:
1. connecting MDs with other MDs
2. connecting life sciences companies with MDs
3. connecting patients with MDs.
Lead app is PGYpal that helps kickstart the careers of MD residents, beginning with oncology.
Dynamiris is developing a sensitive and easy-to-use tool to help in the early identification of neurological disorders using eye-tracking.
Esphera SynBio is developing engineered exosomes for the delivery of specific payloads to target cells using their first-in-class proprietary multimeric fusion protein design.
Eyam Vaccines and Immunotherapeutics Ltd - Platform technologies that create vaccines and immunotherapeutics on demand.
Fibra Inc. is a data-driven women's health platform, with their patent-pending smart underwear plus an app.
FluidAI is a Canadian MedTech company focused on harnessing the power of AI to deliver a new standard of postoperative care.
Fluid Biomed - The company team of neurosurgeons, scientists, and engineers has designed the world’s first hybrid polymer-metal flow-diverting stent to cure this deadly disease.
FOCUS Oncology is developing novel targeted therapies for pancreatic cancer patients. FOCUS is in-licensing a highly active and well tolerated targeted antibody therapeutic currently in a phase II trial, with a FDA Fast Track Designation. Coupled with driving the widespread adoption of next-gen molecular subtyping, FOCUS will accelerate the development of this antibody through to registration in pancreatic cancer. In addition, molecular data generated will be analyzed using a proprietary bespoke bioinformatic platform (TITAN™) to identify novel pancreatic cancer biomarkers for disease screening, treatment, and monitoring.
FOQUS Technologies is tackling the MRI accessibility problem by developing a cloud-based MRI software solution that can reduce scan time, from 60 minutes to less than 5 minutes, without sacrificing imaging quality.
Genomadix is a validated, late stage point of care molecular diagnostic company focused on genotype guided precision medicine and open platform partnerships for adjacent verticals of infectious disease, animal diagnostics and food safety, now entering high growth commercialization.
GLIACHEM is developing novel small molecule therapeutics for Rett Syndrome and neurodegenerative disease.
HDAX Therapeutics is pioneering next-gen precision therapeutics for cardiovascular and neurological diseases by targeting their root causes to enhance patient outcomes.
HeadFirst is revolutionizing concussion testing with saliva based screening.
HTuO Biosciences is a deep-tech company that aims to transform the drug design and discovery process by utilizing advanced computational modelling to target currently undruggable proteins.
Hyivy Health is a medical device company creating the first data driven, remote monitoring solution for gynecological conditions.
Hylid Diagnostics (HyliDx) has developed a prototype home blood test to control life-threatening hyperkalemia, experienced by millions of chronic disease patients in Canada, the US and EU.
InkWell Health sells a novel remote monitoring platform for musculoskeletal patients after an outpatient surgery that monitors a patients swelling, range of motion, temperature, pain and activity after surgery. The platform will help keep patients safe, allow clinicians to optimize in-clinic and home recovery plans, as well as clinic revenues.
Insight Medbotics is a clinical stage medical device company focused on enhancing patient quality of life through our market leading MRI-compatible robotics designed to help more physicians see and target cancers earlier with confidence.
Integrated Nanotherapeutics - Lifting the Burden of Autoimmune Disease with Multi-cargo LNP (Carrying mRNA and Immune Modulators).
InventoRR M.D. Inc. is a medical device startup commercializing our flagship AbClo device to support surgeons and hospitals in the process of closing of intentionally left open abdomens.
JVP Labs is a Congestive Heart Failure (CHF) remote patient monitoring start-up. Our single device provides automated, hospital quality vital sign work up, including Jugular Venous Pressure (JVP) height, in less than 1 minute a read. The system is non invasive, cost effective and easily deployed by elderly patients.
Key Metrix Inc - Our mission with Alytx is to revolutionize healthcare by harnessing cutting-edge technology to improve patient outcomes, enhance accessibility, and streamline medical processes. Through our innovative solutions, we aim to bridge the gap between healthcare and technology, empowering healthcare providers to deliver superior patient-centric care. We remain committed to constant learning and growth, shaping a healthier and smarter future for all.
LUCID develops safe, effective, and accessible audio-based digital therapeutics using cutting-edge machine learning and affective computing techniques to improve neuropsychiatric disorders with an initial focus on those associated with Alzheimer’s dementia.
Luxsonic is transforming the way humans interact with medical imaging using virtual reality and artificial intelligence.
MACH32 is revolutionizing pre-hospital hemorrhage management by developing an "EpiPen" for trauma.
mDETECT is a liquid biopsy company that has developed highly specific and sensitive blood tests for detection and management of numerous cancers including, but not limited to, breast, prostate, ovarian, pancreatic, lung, uveal melanoma, and colorectal with applications in monitoring treatment response, minimal residual disease, and early detection of relapse.
Mediphage Bioceuticals is developing a proprietary and scalable manufacturing process using E.coli to produce a high-fidelity LCC DNA vector, ministring DNA (msDNA), which has applications as a starting material for rAAV and mRNA production, in addition to gene addition, in vivo/ex vivo gene editing and DNA vaccines.
Meridius Bio - Our innovative, derisked AIMER Nanotechnology (Activated Immuno-Modulated Enhanced Regeneration) has been proven to reduce wound healing time by 50-70%, and is ready for clinical development.
Microbion Corporation is developing a novel first in class therapeutic, pravibismane, that has a unique synergistic combination of anti-inflammatory, potent broad-spectrum anti-infective, and anti-biofilm modes of action that is poised to transform inflammation and infection management.
Molecular You is the first and only multi-biomarker analytics platform, providing decision support to clinicians and ACOs based on highly accurate predictive risk profiles in 26+ health areas.
Momentum Health is an AI-based digital health platform for remotely managing spine care.
Nanogenix is a biotechnology company focused on a novel nanoparticle technology that is targeting various cancer types. The 1st in class technology involves an injectbable nanoparticle that is selectively retained in cancer cells and, when activated by a specific wavelength of light, induces cancer cell apoptosis/death without impacting healthy tissue.
NextUp Care is automating healthcare – one appointment at a time.
Noa Therapeutics is a preclinical biotech company pioneering the development of non-steroidal, tri-modal small molecules to address the complexity of inflammatory barrier diseases by simultaneously targeting three key disease drivers to reduce the cycle of treatment failures.
NuvoBio's main goal is to find smart ways of using technology that accelerate drug development and minimize off-target risk. NuvoBio has active peptide drug development programs in oncology and infectious disease.
Orion’s mission is to unlock the therapeutic potential of previously undruggable GPCRs and deliver the next-generation of GPCR-targeted therapeutics with industry leading efficiency.
PhenoTips software is the leading solution for medical genetics used in the US, UK and Canada to address the challenges faced in medical genetics with a single solution, while preparing for the proliferation of genetic testing into mainstream healthcare.
PreOperative Performance Inc. - Validating Magnetic Resonance Imaging Data.
ProteinQure has built the best computational platform for designing small exotic protein therapeutics.
ProteocyteAI is a health technology company that has developed a platform technology with the first application already launched and selling: a test that predicts the risk of progression of oral pre-malignant lesions to invasive cancer.
Providence Therapeutics is a clinical stage biotechnology company specializing in the development of mRNA Medicines.
PulseMedica is laser focused on improving the quality of life for millions of people by building revolutionary technology to image and treat vitreoretinal disease. By integrating 3D imaging, machine learning, and a femtosecond laser, PulseMedica offers new diagnostics, treatment planning, and automated image-guided procedures, ensuring safe, effective, and non-invasive treatment.
PurMinds is a neuro drug development and API supply company focused on promoting neuroplasticity and neuro-rejuvenation.
Qidni Labs is revolutionizing dialysis for kidney failure patients with a portable and nearly waterless dialysis system.
Founded by orthopaedic surgeons, Reach Orthopaedics has developed a shoulder implant to treat middle-aged patients suffering from massive irreparable rotator cuff tears. Reach's shoulder implant is designed to restore shoulder function and reduce chronic pain. It is durable and non-migratory, making it ideal for the middle-aged demographic.
Realize Medical specializes in the application of modern mixed-reality technology to medical imaging and surgical planning, offering an FDA-cleared software platform for collaboratively creating and visualizing 3D anatomical models for use in planning complex medical procedures.
Rhythm Biotherapeutics Inc. - Rhythm Biotherapeutics Inc. is commercializing exosome-based therapies for the prevention and cure of atrial fibrillation, beginning with strong pre-clinical evidence for preventing postoperative atrial fibrillation (POAF), their initial candidate therapy.
Ripple Therapeutics is a clinical stage pharma company focused on improving ophthalmic therapeutics with controllable, sustained drug delivery.
Rocket Doctor is a digital health platform and marketplace that intelligently matches patients with the best clinician for their needs while utilizing AI-fueled software, a unique support system and remote medical devices, and allows clinicians to build and run independent virtual practices, directed to patients on Medicaid and in rural/remote communities across Canada.
Roga is a mental healthcare platform designed to treat anxiety, powered by neurotechnology and AI.
Rostrum’s system is the first system to bring simultaneous monitoring of the heart and lung to ensure optimal and safe ventilation of patients to the bed side to improve patient outcomes and reduce costs.
Scanbo Technologies - Medical diagnostics in the palm of your hand, results in under 5 minutes. No lab required.
Scispot is an AI toolkit for stitching and transforming R&D data. It enables the integration of disparate data and prepares it for machine learning, visualization, and auditing. Scispot accomplishes this by providing a staging lakehouse (data lake) specifically designed for Biotech applications.
Seragene Therapeutics is advancing RNA technology to realize a future where patients with coagulation disorders no longer live in fear of their next bleed or clot.
Skinopathy helps dermatology patients get the right treatment at the right time by arming physicians with tools that enable them to screen, track, and manage skin conditions more effectively.
Sonaro's AI-driven diagnostic imaging software overcomes the limitations of traditional 2D ultrasound imaging by empowering clinicians with precise 3D reconstructed models of the carotid artery and an automated plaque detection, and stroke risk analysis, ultimately reducing operator dependency and examination duration, while saving lives through accurate diagnosis and earlier intervention.
Sonic Incytes is a commercial-stage company with an FDA cleared AI-assisted ultrasound technology revolutionizing the way we diagnose chronic liver disease, a global epidemic affecting over a billion people and causing two million deaths annually.
Sustained Therapeutics is a clinical stage company developing long lasting non-opioid sustained-release therapeutics primarily for the treatment of acute and chronic pain.
Syantra DX: new paradigm RNA-based blood testing platform for the early detection of cancer.
Synakis has developed a novel ocular biomaterial for use as a vitreous substitute for retinal surgery and to deliver engineered therapeutics to treat leading causes of blindness.
TATUM bioscience develops advanced multipronged biologics to crack cancer resistance.
Telescope Therapeutics (TT) is a disease in a dish, iPSC-based drug discovery platform company with a vision to use personalized disease modelling to improve healthcare.
Trexo Robotics is building exoskeletons to help people walk, starting with children with disabilities.
Triple Hair is a clinical-stage biotechnology company dedicated to the development of innovative treatments for androgenic alopecia.
Variational AI uses generative AI to create molecules the world has never seen before that become better medicines faster than ever.
Vasomune is a clinical stage biotech focused on combating vascular dysfunction to stabilize the body as it battles disease.
Vessl Prosthetics helps empower amputees to overcome obstacles and realize their full potential.
Wosler is solving access to healthcare labour for clinics and hospitals, starting with ultrasound technologist labour.
XPAN - Traditional trocar access is still dangerous, costly and inflexible. Xpan has challenged the current standard of care and maximized the potential of MIS access technologies by creating one trocar enabling all instruments.
Yellowbird Diagnostics enhances medical imaging by developing new dyes that visualize invisible biomarkers of disease.
Zilia is a health technology company developing a breakthrough platform to measure biomarkers in the eye, to prevent diagnose and treat various ocular, neurological and systemic conditions.